Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deriving rules and assertions from pharmacogenomics knowledge resources in support of patient drug metabolism efficacy predictions.

Journal of the American Medical Informatics Association : JAMIA - 1 Jan 2000

Overby Casey Lynnette, Devine Emily Beth, Tarczy-Hornoch Peter, Kalet Ira J

Abstract excerpt

OBJECTIVE: Pharmacogenomics evaluations of variability in drug metabolic processes may be useful for making individual drug response predictions. We present an approach to deriving 'phenotype scores' based on existing pharmacogenomics knowledge and a patient's genomics data. Pharmacogenomics play...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Biotransformation
Share to Knowledge Bases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Linear Models

Share to Pharmacogenetics

Share to Precision Medicine

Share to Predictive Value of Tests

Share to Tamoxifen

Source

Open in PubMed Open full text

Identifiers

PMID: 22539082
DOI: 10.1136/amiajnl-2011-000405
PMCID: PMC3422817

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22539082-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deriving rules and assertions from pharmacogenomics knowledge resources in support of patient drug metabolism efficacy predictions.PMID 22539082Read ↗

Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast CancerSemantic proximity Read ↗

A unifying model to predict variable drug response for personalised medicineSemantic proximity Read ↗

Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data.Semantic proximity Read ↗

Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score.Semantic proximity Read ↗

Toward model-informed precision dosing for tamoxifen: A population-pharmacokinetic model with a continuous CYP2D6 activity scale.Semantic proximity Read ↗

Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes.Semantic proximity Read ↗

Leveraging a pharmacogenomics knowledgebase to formulate a drug response phenotype terminology for genomic medicine.Semantic proximity Read ↗

Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients.Semantic proximity Read ↗

Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing.Semantic proximity Read ↗

Using electronic health records for clinical pharmacology research: Challenges and considerations.Semantic proximity Read ↗

Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with TamoxifenSemantic proximity Read ↗

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.